• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. AGILIS¿ INTRODUCER, UNKNOWN; CATHETER, INTRODUCER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. AGILIS¿ INTRODUCER, UNKNOWN; CATHETER, INTRODUCER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Nerve Damage (1979); Cardiac Perforation (2513); Vascular Dissection (3160)
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.The lot number was not provided so a review of the device history record was not possible.Based on the information received, the cause of the reported pericardial effusion, phrenic nerve injury, and dissection could not be conclusively determined.
 
Event Description
Related manufacturing ref: 9680001-2019-00072, 2030404-2019-00030, 2182269-2019-00053.The following was published in crossmark in an article titled, "hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation" by m.I.H.Al-jazairi, m.Rienstra, t.J.Klinkenberg, m.A.Mariani, i.C.Van gelder, and y.Blaauw on 04 february 2019.Fifty patients were included, 57± 9 years, 38 (76%) men, 5 (10%) paroxysmal, 34 (68%) persistent and 11 (22%) long-standing persistent af.At 1-year 38 (76%) maintained sinus rhythm off antiarrhythmi drugs.Majority of recurrences were atrial flutter (9/12 patients).Success was associated with type of af (p= 0.039).Patients with paroxysmal af had highest success, patients with longstanding persistent af had lowest success.Seven (14%) patients had procedure-related complications.Quality of life improved after ablation in patients who maintained sinus rhythm (sr).Seven (14%) patients suffered complications during and after the procedure.Two (4%) had bleeding during the epicardial procedure necessitating thoracotomy; one due to an injury to the pulmonary artery and the other due to injury to the right inferior pulmonary vein.Both patients recovered completely without any sequelae.Two (4%) had permanent phrenic nerve injury, 1 (2%) developed pericardial and pleural effusion requiring drainage, 1 (2%) pleural effusion requiring drainage, and 1 (2%) was known with a latent sick sinus syndrome before the procedure, requiring a ddd-pacemaker after restoration of sr.Total hospital stay was 6± 2 days (tab.4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGILIS¿ INTRODUCER, UNKNOWN
Type of Device
CATHETER, INTRODUCER
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.
14901 deveau place
minnetonka MN 55345
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.
14901 deveau place
minnetonka MN 55345
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key8562549
MDR Text Key143478584
Report Number2182269-2019-00052
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K061363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 04/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/15/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
INQUIRY¿ OPTIMA¿ DIAGNOSTIC CATHETER; SUPREME¿ ELECTROPHYSIOLOGY CATHETER; TACTICATH¿ QUARTZ CONTACT FORCE ABLATION CATHETER
Patient Outcome(s) Other; Required Intervention;
-
-